Back to search

Article

Exploring G-quadruplex structure in <i>PRCC-TFE3</i> fusion Oncogene: Plausible use as anti cancer therapy for translocation Renal cell carcinoma (tRCC)

2023-07-06

Abstract excerpt

The TFE3 fusion gene, byproduct of Xp11.2 translocation, is the diagnostic marker for translocation renal cell carcinoma (tRCC). Absence of any clinically recognized therapy for tRCC, pressing a need to create novel and efficient therapeutic approaches. Previous studies shown that stabilization of the G-quadruplex structure in oncogenes suppresses their expression machinery. To combat the oncogenesis caused by fu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4c9a40df-1bee-545f-ad04-56b64ddc3752
DOI
10.1101/2023.07.06.547934
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring G-quadruplex structure in <i>PRCC-TFE3</i> fusion Oncogene: Plausible use as anti cancer therapy for translocation Renal cell carcinoma (tRCC)DOI 10.1101/2023.07.06.547934
Select a neighboring publication to make it the new centre.